Email this article 
Hide
Show all
Guideline
Southern African HIV Clinicians Society Guidance on the use of dolutegravir in first-line antiretroviral therapy
Submitted: 20 September 2018 | Published: 17 October 2018
About the author(s)
Michelle A. Moorhouse, Wits Reproductive Health and HIV Institute, Faculty of Health Sciences, University of the Witwatersrand, South AfricaSergio Carmona, National Health Laboratory Services, South Africa
Natasha Davies, Wits Reproductive Health and HIV Institute, Faculty of Health Sciences, University of the Witwatersrand, South Africa
Sipho Dlamini, Department of Medicine, University of Cape Town, South Africa
Cloete van Vuuren, Southern African HIV Clinicians Society, South Africa
Thandekile Manzini, Southern African HIV Clinicians Society, South Africa
Moeketsi Mathe, Private Practice, Vereeniging, South Africa
Yunus Moosa, Department of Infectious Diseases, University of KwaZulu-Natal, South Africa
Jennifer Nash, Southern African HIV Clinicians Society, South Africa
Jeremy Nel, Southern African HIV Clinicians Society, South Africa
Yoliswa Pakade, Southern African HIV Clinicians Society, South Africa
Joana Woods, Wits Reproductive Health and HIV Institute, Faculty of Health Sciences, University of the Witwatersrand, South Africa
Gert van Zyl, Southern African HIV Clinicians Society, South Africa
Francesca Conradie, Wits Reproductive Health and HIV Institute, Faculty of Health Sciences, University of the Witwatersrand, South Africa
Francois Venter, Wits Reproductive Health and HIV Institute, Faculty of Health Sciences, University of the Witwatersrand, South Africa
Graeme Meintjes, Department of Medicine and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, South Africa
Abstract
No abstract available.
Keywords
Metrics
Total abstract views: 5894Total article views: 7119
Crossref Citations
1. Clearance of archived integrase strand transfer inhibitors resistance mutations in people with virologically suppressed HIV infection
Basma Abdi, Romain Palich, Sophie Seang, Antoine Fauchois, Théophile Cocherie, Antoine Faycal, Sophie Sayon, Elisa Teyssou, Sanaa Saliba, Cathia Soulie, Marc Antoine Valantin, Valérie Pourcher, Christine Katlama, Vincent Calvez, Anne-Geneviève Marcelin, Marc Wirden
JAC-Antimicrobial Resistance vol: 6 issue: 6 year: 2024
doi: 10.1093/jacamr/dlae194
2. Cardiometabolic Health in Pregnancy and Postpartum: Findings From a Prospective Cohort Study in South Africa
Angela M Bengtson, Hlengiwe Madlala, Mushi J Matjila, Julia H Goedecke, Susan Cu-Uvin, Stephen T McGarvey, Erika Werner, Landon Myer
Open Forum Infectious Diseases vol: 11 issue: 3 year: 2024
doi: 10.1093/ofid/ofae093
3. Dapivirine vaginal ring for HIV prevention: modelling health outcomes, drug resistance and cost‐effectiveness
Robert Glaubius, Yajun Ding, Kerri J Penrose, Greg Hood, Erik Engquist, John W Mellors, Urvi M Parikh, Ume L Abbas
Journal of the International AIDS Society vol: 22 issue: 5 year: 2019
doi: 10.1002/jia2.25282
4. Associations of HIV and antiretroviral therapy with gestational diabetes in South Africa
Angela M. Bengtson, Hlengiwe Madlala, Mushi J. Matjila, Naomi Levitt, Julia H. Goedecke, Susan Cu-Uvin, Stephen T. McGarvey, Erika F. Werner, Landon Myer
AIDS vol: 37 issue: 13 first page: 2069 year: 2023
doi: 10.1097/QAD.0000000000003678
5. HIV-1 integrase strand transfer inhibitors: a review of current drugs, recent advances and drug resistance
Nokuzola Mbhele, Benjamin Chimukangara, Michelle Gordon
International Journal of Antimicrobial Agents vol: 57 issue: 5 first page: 106343 year: 2021
doi: 10.1016/j.ijantimicag.2021.106343
6. Understanding and Responding to Prescribing Patterns of Sodium Valproate-Containing Medicines in Pregnant Women and Women of Childbearing Age in Western Cape, South Africa
Ushma Mehta, Mariette Smith, Emma Kalk, Helen Hayes, Annoesjka Swart, Lawrence Tucker, Renier Coetzee, Andrew Boulle, Marc Blockman
Drug Safety vol: 44 issue: 1 first page: 41 year: 2021
doi: 10.1007/s40264-020-00987-4
7. Drug resistance from preferred antiretroviral regimens for HIV infection in South Africa: A modeling study
Ume L. Abbas, Robert L. Glaubius, Yajun Ding, Gregory Hood, Richard John Lessells
PLOS ONE vol: 14 issue: 7 first page: e0218649 year: 2019
doi: 10.1371/journal.pone.0218649
8. Structural effects of HIV-1 subtype C integrase mutations on the activity of integrase strand transfer inhibitors in South African patients
Nokuzola Mbhele, Michelle Gordon
Journal of Biomolecular Structure and Dynamics vol: 40 issue: 23 first page: 12546 year: 2022
doi: 10.1080/07391102.2021.1972840